drugset / Trial / NCT00399906
A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this clinical research study is to learn if BMS-582949 alone is an effective treatment for moderate to severe psoriasis. The safety of the drug and the effectiveness of each dose will also be studied.
Timeline
- Start
- 2007-08
- Primary completion
- 2009-01
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BMS-582949 | Small molecule | 10 mg | Oral |
| Comparator | BMS-582949 | Small molecule | 30 mg | Oral |
| Comparator | BMS-582949 | Small molecule | 100 mg | Oral |